Restraints and Opportunities: Balancing High Costs with Unmet Needs
While the Desmoid Tumors Market is projected for robust growth, it must navigate significant inherent challenges, primarily the high cost of treatment and management and the persistent lack of adequate healthcare infrastructure in low-income regions. The complexity and rarity of desmoid tumors often necessitate specialized care, molecular testing, and expensive targeted pharmacological agents,...
0 Kommentare 0 Geteilt 156 Ansichten 0 Bewertungen